Response to First-Line Chemotherapy in Patients with Non-Small Cell Lung Cancer According to RRM1 Expression

BACKGROUND: The response to cytotoxic chemotherapy varies greatly in patients with advanced non-small cell lung cancer (NSCLC), and molecular markers may be useful in determining a preferable therapeutic approach for individual patients. This retrospective study was performed to evaluate the predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xiaopeng, Hao, Yingtao, Wei, Yucheng, Yin, Qiuwei, Du, Jiajun, Zhao, Xiaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960222/
https://www.ncbi.nlm.nih.gov/pubmed/24647522
http://dx.doi.org/10.1371/journal.pone.0092320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960222/
https://www.ncbi.nlm.nih.gov/pubmed/24647522
http://dx.doi.org/10.1371/journal.pone.0092320

Ejemplares similares